23 May 2022 , 08:13 AM
Net profit of Zim Laboratories rose 353.55% to Rs 7.03 crore in the quarter ended March 2022 as against Rs 1.55 crore during the previous quarter ended March 2021. Sales rose 42.26% to Rs 105.06 crore in the quarter ended March 2022 as against Rs 73.85 crore during the previous quarter ended March 2021. For the full year,net profit rose 98.77% to Rs 14.55 crore in the year ended March 2022 as against Rs 7.32 crore during the previous year ended March 2021. Sales rose 8.52% to Rs 333.43 crore in the year ended March 2022 as against Rs 307.26 crore during the previous year ended March 2021.
Particulars | Quarter Ended | Year Ended | ||||
? | Mar. 2022 | Mar. 2021 | % Var. | Mar. 2022 | Mar. 2021 | % Var. |
Sales | 105.06 | 73.85 | 42 | 333.43 | 307.26 | 9 |
OPM % | 14.04 | 12.12 | – | 12.29 | 12.94 | – |
PBDT | 14.95 | 6.85 | 118 | 37.08 | 31.20 | 19 |
PBT | 10.77 | 2.67 | 303 | 21.04 | 15.41 | 37 |
NP | 7.03 | 1.55 | 354 | 14.55 | 7.32 | 99 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.